Cargando…
P13-05. Factors associated with pregnancy during the HVTN 503/Phambili trial, a phase IIB HIV trial of the Merck Ad-5 multi-clade HIV vaccine
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2009
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2767678/ http://dx.doi.org/10.1186/1742-4690-6-S3-P187 |
| _version_ | 1782173350772080640 |
|---|---|
| author | Latka, M Grey, G Fielding, K Bekker, L Mlisana, K Nchabeleng, M DeBruin, G Allen, M Kublin, J Churchyard, G |
| author_facet | Latka, M Grey, G Fielding, K Bekker, L Mlisana, K Nchabeleng, M DeBruin, G Allen, M Kublin, J Churchyard, G |
| author_sort | Latka, M |
| collection | PubMed |
| description | |
| format | Text |
| id | pubmed-2767678 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2009 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-27676782009-10-28 P13-05. Factors associated with pregnancy during the HVTN 503/Phambili trial, a phase IIB HIV trial of the Merck Ad-5 multi-clade HIV vaccine Latka, M Grey, G Fielding, K Bekker, L Mlisana, K Nchabeleng, M DeBruin, G Allen, M Kublin, J Churchyard, G Retrovirology Poster Presentation BioMed Central 2009-10-22 /pmc/articles/PMC2767678/ http://dx.doi.org/10.1186/1742-4690-6-S3-P187 Text en Copyright © 2009 Latka et al; licensee BioMed Central Ltd. |
| spellingShingle | Poster Presentation Latka, M Grey, G Fielding, K Bekker, L Mlisana, K Nchabeleng, M DeBruin, G Allen, M Kublin, J Churchyard, G P13-05. Factors associated with pregnancy during the HVTN 503/Phambili trial, a phase IIB HIV trial of the Merck Ad-5 multi-clade HIV vaccine |
| title | P13-05. Factors associated with pregnancy during the HVTN 503/Phambili trial, a phase IIB HIV trial of the Merck Ad-5 multi-clade HIV vaccine |
| title_full | P13-05. Factors associated with pregnancy during the HVTN 503/Phambili trial, a phase IIB HIV trial of the Merck Ad-5 multi-clade HIV vaccine |
| title_fullStr | P13-05. Factors associated with pregnancy during the HVTN 503/Phambili trial, a phase IIB HIV trial of the Merck Ad-5 multi-clade HIV vaccine |
| title_full_unstemmed | P13-05. Factors associated with pregnancy during the HVTN 503/Phambili trial, a phase IIB HIV trial of the Merck Ad-5 multi-clade HIV vaccine |
| title_short | P13-05. Factors associated with pregnancy during the HVTN 503/Phambili trial, a phase IIB HIV trial of the Merck Ad-5 multi-clade HIV vaccine |
| title_sort | p13-05. factors associated with pregnancy during the hvtn 503/phambili trial, a phase iib hiv trial of the merck ad-5 multi-clade hiv vaccine |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2767678/ http://dx.doi.org/10.1186/1742-4690-6-S3-P187 |
| work_keys_str_mv | AT latkam p1305factorsassociatedwithpregnancyduringthehvtn503phambilitrialaphaseiibhivtrialofthemerckad5multicladehivvaccine AT greyg p1305factorsassociatedwithpregnancyduringthehvtn503phambilitrialaphaseiibhivtrialofthemerckad5multicladehivvaccine AT fieldingk p1305factorsassociatedwithpregnancyduringthehvtn503phambilitrialaphaseiibhivtrialofthemerckad5multicladehivvaccine AT bekkerl p1305factorsassociatedwithpregnancyduringthehvtn503phambilitrialaphaseiibhivtrialofthemerckad5multicladehivvaccine AT mlisanak p1305factorsassociatedwithpregnancyduringthehvtn503phambilitrialaphaseiibhivtrialofthemerckad5multicladehivvaccine AT nchabelengm p1305factorsassociatedwithpregnancyduringthehvtn503phambilitrialaphaseiibhivtrialofthemerckad5multicladehivvaccine AT debruing p1305factorsassociatedwithpregnancyduringthehvtn503phambilitrialaphaseiibhivtrialofthemerckad5multicladehivvaccine AT allenm p1305factorsassociatedwithpregnancyduringthehvtn503phambilitrialaphaseiibhivtrialofthemerckad5multicladehivvaccine AT kublinj p1305factorsassociatedwithpregnancyduringthehvtn503phambilitrialaphaseiibhivtrialofthemerckad5multicladehivvaccine AT churchyardg p1305factorsassociatedwithpregnancyduringthehvtn503phambilitrialaphaseiibhivtrialofthemerckad5multicladehivvaccine |